| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $38,004,147 ) (Continued on the next page) |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166608 | Disease-specific risk factors for thrombosis following vascular interventions | 000 | 3 | NIH | 7/23/2025 | $678,195 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08DA058052 | Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder | 000 | 3 | NIH | 4/7/2025 | $186,527 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08AI166125 | Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection | 000 | 4 | NIH | 8/13/2025 | $193,752 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | D4054828 | Graduate Psychology Education Programs | 00 | 1 | HRSA | 6/11/2025 | $449,998 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA058367 | PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study | 000 | 3 | NIH | 6/18/2025 | $1,113,072 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 001 | 2 | NIH | 8/5/2025 | $0 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 001 | 2 | NIH | 8/5/2025 | $0 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 000 | 2 | NIH | 7/23/2025 | $175,212 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK140570 | THRIVE-DM: Improving Diabetes Care with Strategies for Addressing Health-Related Social Needs and Community Partnerships | 000 | 2 | NIH | 7/23/2025 | $344,666 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK134616 | Significance of Tubuloglomerular Feedback in SGLT1 and SGLT2 Inhibition in Diabetic Kidney Disease | 000 | 4 | NIH | 3/21/2025 | $372,536 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | 90ZT0224 | The Moving Forward Initiative for Survivors of Torture and Their Families | 00 | 4 | ACF | 9/5/2025 | $487,341 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | S10OD038188 | Utilization of BioDot Omnia Automated Liquid Dispensing/Handling System to Enhance the Efficiency and Accuracy of High Throughput Biological Assays | 000 | 1 | NIH | 5/7/2025 | $248,756 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | S10OD038188 | Utilization of BioDot Omnia Automated Liquid Dispensing/Handling System to Enhance the Efficiency and Accuracy of High Throughput Biological Assays | 000 | 1 | NIH | 5/7/2025 | $1 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD109005 | Investigating structural maternal health inequities among Black reproductive aged women in Georgia: a mixed methods and multi-level approach | 001 | 4 | NIH | 4/24/2025 | $468,191 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD109005 | Investigating structural maternal health inequities among Black reproductive aged women in Georgia: a mixed methods and multi-level approach | 005 | 4 | NIH | 6/11/2025 | $2,644 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD109005 | Investigating structural maternal health inequities among Black reproductive aged women in Georgia: a mixed methods and multi-level approach | 005 | 4 | NIH | 6/11/2025 | $461,570 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AA030460 | Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" | 003 | 4 | NIH | 9/24/2025 | $103,298 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AA030460 | Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" | 002 | 4 | NIH | 9/23/2025 | -$103,298 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AA030460 | Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" | 001 | 4 | NIH | 9/9/2025 | $125,447 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AA030460 | Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention" | 000 | 4 | NIH | 9/4/2025 | $550,619 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK133404 | Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration | 000 | 4 | NIH | 4/23/2025 | $577,631 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 000 | 5 | NIH | 3/24/2025 | $216,099 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 001 | 5 | NIH | 5/5/2025 | $2,660 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK118267 | Nucleophosmin Centered Diagnostics and Treatment of Ischemic Acute Kidney Injury | 001 | 6 | NIH | 4/8/2025 | $471,531 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K24AT011561 | Mentoring and Patient-Oriented Research in Mind and Body Practices | 000 | 5 | NIH | 8/13/2025 | $121,371 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL178832 | Niche-specific endothelial mechanisms regulating the extravasation of hematopoietic stem cells | 000 | 1 | NIH | 4/29/2025 | $734,607 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03DA064474 | Immune profiling of antibodies and B cells that recognize HIV and substances in people who use substances and live with HIV (PWUSH) | 000 | 1 | NIH | 8/20/2025 | $356,630 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P01AA029541 | The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | 001 | 5 | NIH | 9/18/2025 | $335,921 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | P01AA029541 | The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | 000 | 5 | NIH | 9/16/2025 | $1,082,689 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DK128858 | The Boston University Kidney and Medical Engineering Program (BU-KIDMEP) | 000 | 5 | NIH | 7/31/2025 | $122,792 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 001 | 5 | NIH | 9/26/2025 | $20,698 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 000 | 5 | NIH | 9/24/2025 | $165,751 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA055488 | Persistent HIV-1 expression and microglia dysfunction | 000 | 5 | NIH | 5/7/2025 | $729,537 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HS028814 | Implementing Telemedicine to Improve Appropriate Antibiotic Prescribing for Acute Respiratory Tract Infections | 001 | 4 | AHRQ | 6/5/2025 | $483,567 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R13DA064395 | Academic Consortium of Criminal Justice Health | 001 | 1 | NIH | 9/12/2025 | $77,199 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R13DA064395 | Academic Consortium of Criminal Justice Health | 000 | 1 | NIH | 9/3/2025 | $1 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H79SM084960 | Boston Services for Trauma And Resources for families (Boston STAR) | 002 | 5 | SAMHSA | 9/15/2025 | $391,666 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HG014487 | Scalable software engineering and methods for large-scale subcellular spatial omics | 000 | 1 | NIH | 8/15/2025 | $3,371,645 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08HL177161 | Developing models of placenta-driven developmental lung injury in human preeclampsia | 000 | 1 | NIH | 8/18/2025 | $166,752 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA059908 | Clinical Undergraduate Research in Addictions - Training and Experiences (CURATE) Program | 000 | 1 | NIH | 7/11/2025 | $134,697 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH138549 | Adaptive interventions to improve posttraumatic stress (PTSD) treatment access, engagement, and effectiveness in routine care | 000 | 1 | NIH | 7/29/2025 | $939,784 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA060588 | Massachusetts HIV and Justice-Involved Populations Research Network | 000 | 3 | NIH | 8/8/2025 | $1,532,176 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA060588 | Massachusetts HIV and Justice-Involved Populations Research Network | 001 | 3 | NIH | 9/3/2025 | $6,018 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA033211 | Advancing Clinical Research Training within Addiction Residency Programs | 002 | 12 | NIH | 5/2/2025 | $366,591 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH128639 | Medicaid Accountable Care Organizations (ACO) and Quality of Care for Adults with Serious Mental Illness (SMI) | 000 | 4 | NIH | 3/13/2025 | $189,432 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 002 | 3 | NIH | 4/20/2025 | $162,187 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 003 | 3 | NIH | 9/6/2025 | $0 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI186597 | The relationship between HIV exposure, contact networks, and TB in children under 5 years old | 000 | 2 | NIH | 8/28/2025 | $190,512 |
| | 2025 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21CA286402 | Delineating the myeloid-centric immunosuppressive crosstalk as targets for prognosis and therapy in neuroendocrine tumors | 001 | 2 | NIH | 6/11/2025 | $24,675 |
|
